Seer Inc (NAS:SEER)
$ 2.47 -0.03 (-1.2%) Market Cap: 145.65 Mil Enterprise Value: -75.45 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 56/100

Seer Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 12:35PM GMT
Release Date Price: $9.73 (-4.79%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Welcome. I'm Tejas Savant. I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure to host Seer this morning, and from the company, we have Omid Farokhzad and David Horn, CEO and CFO. So thanks, gents, for joining us.

Before I kick it off with the Q&A, research disclosures, please see the Morgan Stanley website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Omid, thanks for doing this again. And maybe just to set the stage, clearly an exciting year for you guys following the commercial launch of the Proteograph. Can you just highlight what you view as your key accomplishments year-to-date? And what are you most excited about heading into '23?

Omid C. Farokhzad
Seer, Inc. - Founder, CEO & Chair of the Board of Directors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot